(RTTNews) - Myriad Genetics Inc. (MYGN) said that it has entered into a partnership with Gabbi, a telehealth platform specializing in breast cancer risk assessment and specialist care. The ...
The companies will work together to provide an integrated offering that combines Gabbi’s risk assessment program and access to breast specialists with Myriad’s MyRisk ® with RiskScore ® Here ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback